The Zhitong Finance App learned that BMO Capital Markets downgraded its stock rating of Leander Basel (LYB.US) from “on par with the market” to “outperforming the market”, and warned that increasing commodity and financial pressure may continue to drag down the chemical group until 2026. BMO lowered its target price for the stock from $48 to $36 and said the valuation reflects ongoing challenges associated with weak demand for commodities, pressure on margins, and a lack of a catalyst for improvement in the short term.

The Zhitong Finance App learned that BMO Capital Markets downgraded its stock rating of Leander Basel (LYB.US) from “on par with the market” to “outperforming the market”, and warned that increasing commodity and financial pressure may continue to drag down the chemical group until 2026. BMO lowered its target price for the stock from $48 to $36 and said the valuation reflects ongoing challenges associated with weak demand for commodities, pressure on margins, and a lack of a catalyst for improvement in the short term.